Board Meeting13 Aug 2026, 11:00 pm
Bilcare Ltd Board Approves Unaudited Q1 FY27 Results, Director Changes
AI Summary
Bilcare Limited's Board of Directors met on August 13, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The board also approved the appointment of Mr. Mohan Bhandari as Executive Director and the reappointment of Ms. Kavita Bhansali as Executive Director. Additionally, Mr. Sagar R. Baheti resigned as Company Secretary and Compliance Officer, with Mr. Mayur Dave appointed to these roles. The company also proposed the voluntary winding up of its wholly-owned US subsidiary, Bilcare INC.
Key Highlights
- Board approved unaudited standalone and consolidated financial results for Q1 FY27.
- Mr. Mohan Bhandari appointed as Executive Director.
- Ms. Kavita Bhansali reappointed as Executive Director.
- Changes in Company Secretary and Compliance Officer roles approved.
- Proposal to voluntarily wind up US subsidiary, Bilcare INC.
Price Impact
More from BI
More in Board Meeting